UNC study: Nanoparticle-formulated drug combination effective in medulloblastoma

Uninterrupted Medicaid coverage improves survival for kids with cancer

Continuity of Medicaid coverage increases the survival rates of children and adolescents with cancer, according to research published in JCO Oncology Practice.

October 11, 2024

Vol.50 No.38

In Brief

Israel’s only cancer hospital opens Adolescent & Young Adult Cancer Clinic

The Davidoff Comprehensive Cancer Center, Israel’s only cancer hospital, opened an Adolescent & Young Adult Cancer Clinic to help patients going through treatment between the ages of 18-44.

July 26, 2024

Vol.50 No.30

Clinical Roundup

Unexpected role of OTX2 drives aggressive medulloblastoma

Researchers at Baylor College of Medicine, Texas Children’s Hospital, the University of Manitoba, and collaborating institutions revealed an unexpected way in which the protein OTX2 drives the progression of medulloblastoma—the most common aggressive childhood brain cancer.

July 19, 2024

Vol.50 No.29

Clinical

RWE study pinpoints gaps in mental health care utilization among parents of children with cancer

Unquestionably, a child’s cancer diagnosis weighs heavily on the parents’ minds. But now, an analysis of nearly 30,000 U.S. families has quantified how often parents of children with cancer use mental health services.

May 17, 2024

Vol.50 No.20

By McKenzie Prillaman

In Brief

Jezabel Rodriguez Blanco granted $800,000 from Alex’s Lemonade Stand to study medulloblastoma relapse

Jezabel Rodriguez Blanco, who has a dual appointment at MUSC Hollings Cancer Center and the Darby Children’s Research Institute at MUSC, will receive $800,000 over four years from Alex’s Lemonade Stand Foundation for Childhood Cancer to continue her pursuit of the causes of medulloblastoma relapse.

January 19, 2024

Vol.50 No.03

In Brief

Baylor, Texas Children’s awarded $7.6M to study disparities for Latino survivors of childhood cancer

Researchers at Baylor College of Medicine and Texas Children’s Cancer Center were awarded more than $7.6 million over four years from NCI to comprehensively study late effects of childhood cancer in a diverse population of childhood cancer survivors, including their medical, neurocognitive, and psychosocial outcomes. In addition, they will evaluate potential educational and sociodemographic barriers to obtaining survivorship care.

August 11, 2023

Vol.49 No.32

UNC study: Nanoparticle-formulated drug combination effective in medulloblastoma

YOU MAY BE INTERESTED IN

Uninterrupted Medicaid coverage improves survival for kids with cancer

Israel’s only cancer hospital opens Adolescent & Young Adult Cancer Clinic

Unexpected role of OTX2 drives aggressive medulloblastoma

RWE study pinpoints gaps in mental health care utilization among parents of children with cancer

Jezabel Rodriguez Blanco granted $800,000 from Alex’s Lemonade Stand to study medulloblastoma relapse

Baylor, Texas Children’s awarded $7.6M to study disparities for Latino survivors of childhood cancer

Renew today!

Subscriber content

Never miss an issue!

Login